Document Detail

Platelet glycoprotein IIb/IIIa receptor blockade therapy for large coronary aneurysms and thrombi in Kawasaki disease.
MedLine Citation:
PMID:  9829884     Owner:  NLM     Status:  MEDLINE    
A 4-month-old girl with Kawasaki disease, large coronary artery aneurysms, and coronary thrombi was treated with standard therapy followed by abciximab, a platelet glycoprotein IIb/IIIa antagonist, in addition to standard heparin and warfarin sodium anticoagulation and low-dose aspirin. She did not develop evidence of ischemia, had no complications from the therapy, and showed resolution of the aneurysms and thrombi after 6 wk of therapy.
S P Etheridge; L Y Tani; L L Minich; J R Revenaugh
Related Documents :
11916444 - Coronary artery bypass grafting in an adult case with kawasaki disease.
10455084 - Safety of the transpulmonary ultrasound contrast agent nc100100: a clinical and haemody...
21717304 - Ruptured aneurysm with extravasation observed in four-dimensional computed tomography a...
2756894 - Type a behavior: its diagnosis, cardiovascular relation and the effect of its modificat...
18388044 - Chronic effort-induced angina as presentation of a totally occluded left main coronary ...
9641274 - Advantages of sharp adventitial dissection for microvascular anastomoses.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Catheterization and cardiovascular diagnosis     Volume:  45     ISSN:  0098-6569     ISO Abbreviation:  Cathet Cardiovasc Diagn     Publication Date:  1998 Nov 
Date Detail:
Created Date:  1999-01-20     Completed Date:  1999-01-20     Revised Date:  2013-05-24    
Medline Journal Info:
Nlm Unique ID:  7508512     Medline TA:  Cathet Cardiovasc Diagn     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  264-8     Citation Subset:  IM    
Department of Pediatrics, University of Utah and Primary Children's Medical Center, Salt Lake City 84113, USA. pcs
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antibodies, Monoclonal / therapeutic use
Anticoagulants / therapeutic use
Aspirin / therapeutic use
Cardiac Catheterization
Coronary Aneurysm / complications,  diagnosis,  drug therapy*
Coronary Angiography
Coronary Thrombosis / complications,  diagnosis,  drug therapy*
Drug Therapy, Combination
Follow-Up Studies
Immunoglobulin Fab Fragments / therapeutic use
Immunoglobulins, Intravenous / therapeutic use
Mucocutaneous Lymph Node Syndrome / blood,  complications*,  diagnosis
Platelet Aggregation Inhibitors / therapeutic use*
Platelet Count
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Anticoagulants; 0/Immunoglobulin Fab Fragments; 0/Immunoglobulins, Intravenous; 0/Platelet Aggregation Inhibitors; 0/Platelet Glycoprotein GPIIb-IIIa Complex; 50-78-2/Aspirin; X85G7936GV/abciximab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The acute outcome of tibioperoneal vessel angioplasty in 417 cases with claudication and critical li...
Next Document:  Transcatheter closure of an anomalous venous connection by a novel method.